Renalytix plc 10-K Item 1C. Cybersecurity - 2023-09-28
Renalytix plc disclosed their cybersecurity strategy, risk management and governance process in an annual SEC Filing 10-K filing on 2023-09-28 06:18:37 EDT
Company Summary
Renalytix plc develops and commercializes KidneyIntelX, an AI-enabled in‑vitro prognostic diagnostic platform (kidneyintelX.dkd) that combines blood biomarkers and EHR data to assess risk of progressive kidney function decline in adults with type 2 diabetes; testing services are provided through its CLIA‑certified laboratories and a cloud-based portal.
Looking for governance insights?
View the comprehensive Cyber Governance Profile for Renalytix plc.
Filings
10-K filed on 2023-09-28
Renalytix plc filed an SEC Filing 10-K filing on 2023-09-28 06:18:37 EDT.
Accession Number: 0000950170-23-050231
Item 1C. Cybersecurity
Item 1C - Cybersecurity
Item 1C. Cybersecurity
Not applicable.
Company
Profile
| Name | Renalytix plc |
|---|---|
| CIK | 1811115 |
| SIC Description | |
| Industry | |
| Ticker | RNLXY RENXF |
| Website | |
| Category | Non-accelerated Filer |
| Fiscal Year End | June 30 |